Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
2.
Pharmacy (Basel) ; 8(3)2020 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-32877997

RESUMEN

Over the last four decades, the expanded patient care roles of pharmacists in the United States (U.S.) have increased focus on ensuring the implementation of processes to enhance continuing professional development within the profession. The transition from a model of continuing pharmacy education (CPE) to a model of continuing professional development (CPD) is still evolving. As pharmacists assume more complex roles in patient care delivery, particularly in community-based settings, the need to demonstrate and maintain professional competence becomes more critical. In addition, long-held processes for post-graduate education and licensure must also continue to adapt to meet these changing needs. Members of the pharmacy profession in the U.S. must adopt the concept of CPD and implement processes to support the thoughtful completion of professional development plans. Comprehensive, state-of-the-art technology solutions are available to assist pharmacists with understanding, implementing and applying CPD to their professional lives.

3.
J Am Pharm Assoc (2003) ; 60(1): 47-56, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31669419

RESUMEN

OBJECTIVES: To describe the views of pharmacists and student pharmacists regarding (1) aspects of life and experiences that provide professional and personal satisfaction and fulfillment, (2) causes of stress, and (3) needs related to maintaining satisfaction and fulfillment. DESIGN: A generic qualitative research design was used for collecting data from 380 pharmacists and 332 student pharmacists who wrote responses to an online survey hosted by the American Pharmacists Association (APhA) from November 17 to December 2, 2018, using standard data collection procedures applied by that organization. APhA uses its member and affiliate data files as its sampling frame and limits the number of contacts per year for each person in those files. De-identified responses from those who volunteered to write comments were sent to the research team for analysis. A conventional content analysis approach was applied for analysis of the text. Analysts convened to discuss emergent themes and develop operational descriptions. Key segments of text that best represented each theme were identified. Personal presuppositions were disclosed and were useful for developing group consensus for theme identification and description. Rigor was supported through assessment of credibility, confirmability, intercoder checking, transferability, inductive thematic saturation, and authenticity. SETTING AND PARTICIPANTS: Participants are in the design since data already collected. OUTCOME MEASURES: Not applicable. RESULTS: Findings showed that pharmacists and student pharmacists are able to recognize and pursue achievement, recognition, responsibility, advancement, relationship, esteem, self-actualization, meaning, and accomplishment in both their professional and personal lives. However, external factors such as "workism" and individual factors such as "moral distress" were identified as areas of improvement that are needed for well-being and resilience. CONCLUSION: Pharmacists' basic human needs are being met, but to improve well-being and resilience for pharmacists in both their professional and personal lives, there is a need for addressing both the external factors and individual factors that they encounter.


Asunto(s)
Satisfacción Personal , Farmacéuticos , Actitud del Personal de Salud , Recolección de Datos , Humanos , Rol Profesional , Investigación Cualitativa , Estudiantes
4.
Am J Pharm Educ ; 83(4): 7245, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-31223169

RESUMEN

Postgraduate year one (PGY1) community-based pharmacy residency programs are intended to build upon the Doctor of Pharmacy (PharmD) education and outcomes. The goal of the residency program is to develop community-based pharmacist practitioners with diverse patient care, leadership, and education skills. This commentary will inform faculty mentors about the history, evolution, structure, and design of PGY1 community-based pharmacy residency programs. This commentary will also review the equivalency of PGY1 community-based pharmacy residency programs to other PGY1 programs, specifically to PGY1 pharmacy programs typically administered in hospitals and health systems. Faculty who are knowledgeable about PGY1 community-based pharmacy residency programs will be able to provide mentorship and promotion for student pharmacists who are interested in direct patient care.


Asunto(s)
Servicios Comunitarios de Farmacia/organización & administración , Docentes de Farmacia/organización & administración , Residencias en Farmacia/organización & administración , Estudiantes de Farmacia , Competencia Clínica , Humanos , Mentores , Farmacéuticos/organización & administración , Farmacéuticos/normas
5.
J Am Pharm Assoc (2003) ; 56(5): 584-589.e1, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27594109

RESUMEN

OBJECTIVES: The Community Pharmacy Residency Program (CPRP) Planning Committee convened to develop a vision and a strategic action plan for the advancement of community pharmacy residency training. Aligned with the profession's efforts to achieve provider status and expand access to care, the Future Vision and Action Plan for Community-based Residency Training will provide guidance, direction, and a strategic action plan for community-based residency training to ensure that the future needs of community-based pharmacist practitioners are met. DATA SOURCES: National thought leaders, selected because of their leadership in pharmacy practice, academia, and residency training, served on the planning committee. The committee conducted a series of conference calls and an in-person strategic planning meeting held on January 13-14, 2015. Outcomes from the discussions were supplemented with related information from the literature. Results of a survey of CPRP directors and preceptors also informed the planning process. SUMMARY: The vision and strategic action plan for community-based residency training is intended to advance training to meet the emerging needs of patients in communities that are served by the pharmacy profession. The group anticipated the advanced skills required of pharmacists serving as community-based pharmacist practitioners and the likely education, training and competencies required by future residency graduates in order to deliver these services. The vision reflects a transformation of community residency training, from CPRPs to community-based residency training, and embodies the concept that residency training should be primarily focused on training the individual pharmacist practitioner based on the needs of patients served within the community, and not on the physical location where pharmacy services are provided. CONCLUSION: The development of a vision statement, core values statements, and strategic action plan will provide support, guidance, and direction to the profession of pharmacy to continue the advancement and expansion of community-based residency training.


Asunto(s)
Servicios Comunitarios de Farmacia/organización & administración , Farmacéuticos/organización & administración , Residencias en Farmacia/organización & administración , Competencia Clínica , Servicios Comunitarios de Farmacia/tendencias , Humanos , Liderazgo , Farmacéuticos/tendencias , Residencias en Farmacia/tendencias , Rol Profesional
6.
J Am Pharm Assoc (2003) ; 53(2): e125-31, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23571635

RESUMEN

OBJECTIVE: To describe the types of services provided at primary community pharmacy residency program (CPRP) sites and the levels of intensity devoted to different levels of patient care. DESIGN: Descriptive nonexperimental study. SETTING: United States during May and June 2012. PARTICIPANTS: 120 key informants from CPRPs. INTERVENTION: Key informants from CPRPs were surveyed. MAIN OUTCOME MEASURES: Proportion of residency sites providing selected patient care services, proportion of each service provided by residents, estimates for the number of repetitions needed for a typical resident to become proficient in each service, and services provided at other practice sites. RESULTS: Of the 120 respondents, 70 identified themselves as preceptors/directors, 45 identified themselves as residents, and 5 did not identify their position. Variation was achieved for representation from different practice settings and geographic locations. The findings revealed variability in the types of services provided at CPRP practice sites and the experiences offered for residents. Collaboration with other practice sites, in order to enhance residents' training and experiences, also appeared to be occurring. CONCLUSION: The results showed that the types and intensity of services provided at CPRP sites gave residents opportunities for advancing patient care services training, directing patient contact, and creating opportunities to be engaged in practice innovation.


Asunto(s)
Servicios Comunitarios de Farmacia , Educación en Farmacia , Internado no Médico , Farmacias , Humanos , Atención al Paciente , Estados Unidos
7.
Am J Pharm Educ ; 75(8): 160, 2011 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-22102750

RESUMEN

Clinical pharmacy services necessitate appropriately trained pharmacists. Postgraduate year one (PGY1) community pharmacy residency programs (CPRPs) provide advanced training for pharmacists to provide multiple patient care services in the community setting. These programs provide an avenue to translate innovative ideas and services into clinical practice. In this paper, we describe the history and current status of PGY1 community pharmacy residency programs, including an analysis of the typical settings and services offered. Specific information on the trends of community programs compared with other PGY1 pharmacy residencies is also discussed. The information presented in this paper is intended to encourage discussion regarding the need for increasing the capacity of PGY1 community pharmacy residency programs.


Asunto(s)
Educación Continua en Farmacia/tendencias , Farmacias/tendencias , Farmacéuticos/tendencias , Desarrollo de Programa , Humanos
8.
Psychopharmacology (Berl) ; 207(1): 27-34, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19662384

RESUMEN

PURPOSE: Citalopram, a selective serotonin reuptake inhibitor, is used as a neuroendocrine probe in human subjects to assess serotonin function as reflected in prolactin and plasma cortisol release. Citalopram is a racemic mixture of equal proportions of the S(+) and R(-) enantiomers. Inhibition of serotonin reuptake and, consequently, antidepressant activity is associated, almost exclusively, with the S(+) enantiomer ("escitalopram"). Studies in animal models indicate that the presence of the R(-) isomer may interfere with the serotonin reuptake activity of escitalopram. The current study compared the neuroendocrine effects of citalopram and escitalopram in healthy human volunteers. METHODS: Plasma cortisol and prolactin levels following a single oral dose of citalopram (40 mg) or escitalopram (20 mg) were compared in samples taken every 15-30 min over a period of 240 min. Plasma citalopram concentration was determined at the same intervals. RESULTS: Escitalopram and citalopram caused equivalent increases in plasma cortisol and prolactin. The administration of dexamethasone prior to the escitalopram challenge blocked the evoked increase in cortisol. CONCLUSION: This is the first study to prove that a single dose of escitalopram acts centrally and not peripherally, providing further support of the use of oral escitalopram as a probe for brain serotonergic function.


Asunto(s)
Antidepresivos de Segunda Generación/farmacología , Citalopram/farmacología , Hidrocortisona/sangre , Prolactina/sangre , Adulto , Análisis de Varianza , Área Bajo la Curva , Dexametasona , Humanos , Masculino , Persona de Mediana Edad , Método Simple Ciego , Factores de Tiempo
9.
J Am Pharm Assoc (2003) ; 49(3): 392-8, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19443319

RESUMEN

OBJECTIVES: To determine patients' perceptions and expectations about medication therapy management (MTM) services pertaining to the core elements of an MTM service in the community pharmacy setting, and to develop educational strategies and outreach programs aimed at increasing patients' knowledge of MTM services and the expanded role of pharmacists in the community pharmacy setting. DESIGN: Multicenter, cross-sectional, anonymous study. SETTING: Four regional community chain pharmacies in Maryland and Delaware in January and February 2006. PATIENTS: 81 patients who were 18 years of age or older and able to complete the survey. INTERVENTION: Survey containing 14 questions administered within pharmacies, two of which had patient care centers that were providing clinical services. MAIN OUTCOME MEASURE: Patients' perceptions and expectations regarding MTM services. RESULTS: 49 of 81 patients (60%) had never heard of MTM services. A total of 65 patients (80%) had never had or received a medication therapy review, 63 (78%) never had or received a personal medication record, and 70 (86%) never had or received a medication action plan. Some 56% of participants (n = 45) thought that pharmacist provision of medication therapy reviews, personal medication records, medication action plans, recommendations about medications, and referral to other health care providers was very important. At least 70% of participants (n = 57) thought that having one-on-one consultation sessions with pharmacists to improve communication and relationships with their pharmacists and to improve their medication use and overall health was very important. More than 50% of participants indicated that they would like to receive brochures or talk to their pharmacist to learn more about MTM services. CONCLUSION: Patients have very limited knowledge of the core elements of an MTM service in the community pharmacy setting. Patients reported that pharmacist provision of MTM services was important, but they were concerned about privacy and pharmacists' time. Patients are also supportive of and believe that MTM services can improve communication and relationship with their pharmacist and improve medication use. Patients appear to prefer receiving brochures and talking to pharmacists to learn more about MTM services. This survey identified a key opportunity for pharmacists to inform patients about MTM services.


Asunto(s)
Servicios Comunitarios de Farmacia/organización & administración , Administración del Tratamiento Farmacológico/organización & administración , Aceptación de la Atención de Salud/estadística & datos numéricos , Farmacéuticos/organización & administración , Adolescente , Adulto , Anciano , Estudios Transversales , Recolección de Datos , Delaware , Conocimientos, Actitudes y Práctica en Salud , Humanos , Maryland , Medicare Part D/organización & administración , Persona de Mediana Edad , Educación del Paciente como Asunto , Privacidad/psicología , Estados Unidos , Adulto Joven
10.
Artículo en Inglés | MEDLINE | ID: mdl-16563590

RESUMEN

Citalopram, a selective serotonin reuptake inhibitor (SSRI), has been used as a neuroendocrine probe to assess serotonin (5-HT) function in human subjects. In an effort to characterize the oral citalopram challenge, we hypothesized that oral racemic citalopram would increase plasma cortisol, prolactin and adrenocorticotropic hormone (ACTH) concentrations; ACTH had not been measured in previous studies on the neuroendocrine effects of citalopram. Nine healthy male subjects initially received 20 mg of citalopram in an open-label study, and subsequently received placebo and 40 mg of citalopram in a single-blind, randomized, cross-over study. The administration of citalopram 20 mg failed to produce a significant neuroendocrine response but 40 mg resulted in reliably increased plasma cortisol concentrations. The 40 mg dose, however, did not reliably influence the levels of plasma prolactin or plasma ACTH. The results of this study indicate that caution should be used in accepting oral racemic citalopram as a potential presynaptic serotonergic challenge agent. Further studies are needed to fully determine the validity of racemic citalopram and the active enantiomer, escitalopram, as 5-HT probes.


Asunto(s)
Citalopram/administración & dosificación , Sistemas Neurosecretores/efectos de los fármacos , Inhibidores Selectivos de la Recaptación de Serotonina/administración & dosificación , Administración Oral , Hormona Adrenocorticotrópica/sangre , Adulto , Estudios Cruzados , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática/métodos , Humanos , Hidrocortisona/sangre , Masculino , Persona de Mediana Edad , Sistemas Neurosecretores/metabolismo , Prolactina/sangre , Método Simple Ciego , Factores de Tiempo
13.
Artículo en Inglés | MEDLINE | ID: mdl-11817518

RESUMEN

A pilot study was conducted in schizophrenic patients with primary polydipsia to determine the tolerability of adding clonidine to an existing antipsychotic drug regimen and to seek evidence of an antidipsic effect. Three patients with chronic schizophrenia and primary polydipsia underwent open controlled prospective trials of treatment with clonidine in doses of up to 800 microg/day. The trials lasted from 2 to 5 months each, and analysis of variance was used to test for changes in dependent variables on a case-by-case basis. Blood pressure and pulse declined significantly in a dose-dependent manner, but fluid intake, as assessed by measurements of weight and 24-h urine volume, was not affected. Hypotension and bradycardia limited the extent to which the dose of clonidine could be increased. The lack of evident effect of clonidine on polydipsia in this small sample and the inconsistent results of two other recent studies of clonidine in patients with schizophrenia and primary polydipsia provide little overall support for the effectiveness of clonidine treatment in primary polydipsia associated with schizophrenia.


Asunto(s)
Clonidina/farmacología , Clonidina/uso terapéutico , Conducta de Ingestión de Líquido/efectos de los fármacos , Esquizofrenia/tratamiento farmacológico , Intoxicación por Agua/tratamiento farmacológico , Agonistas alfa-Adrenérgicos/efectos adversos , Agonistas alfa-Adrenérgicos/farmacología , Agonistas alfa-Adrenérgicos/uso terapéutico , Adulto , Análisis de Varianza , Enfermedad Crónica , Clonidina/efectos adversos , Relación Dosis-Respuesta a Droga , Conducta de Ingestión de Líquido/fisiología , Humanos , Masculino , Proyectos Piloto , Estudios Prospectivos , Esquizofrenia/orina , Sed/efectos de los fármacos , Sed/fisiología , Intoxicación por Agua/psicología , Intoxicación por Agua/orina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA